British randomised controlled trial of AV and VV optimization (“BRAVO”) study: rationale, design, and endpoints

Ítems similars

• Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy: The BRAVO Trial
  per: Whinnett, Zachary I., et al.
  Publicat: (2019)
• Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant
  per: Sohaib, S.M. Afzal, et al.
  Publicat: (2015)
• Distinct impacts of heart rate and right atrial‐pacing on left atrial mechanical activation and optimal AV delay in CRT
  per: Kyriacou, Andreas, et al.
  Publicat: (2018)
• Cardiac resynchronization therapy and AV optimization increase myocardial oxygen consumption, but increase cardiac function more than proportionally()
  per: Kyriacou, Andreas, et al.
  Publicat: (2014)
• The Acute Effects of Changes to AV Delay on Blood Pressure and Stroke Volume: Potential Implications for Design of Pacemaker Optimization Protocols
  per: Manisty, Charlotte H., et al.
  Publicat: (2011)